Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion type Assertion NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_head.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion description "[ The data suggest that the PPARalpha polymorphism L162V might protect against the development of atherosclerosis or CHD in patients with DM-2. The absence of an association between the polymorphism and plasma lipoprotein concentrations may suggest that th]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_provenance.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion evidence source_evidence_literature NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_provenance.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion SIO_000772 15199365 NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_provenance.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion wasDerivedFrom gad-20150221 NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_provenance.
- NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_assertion wasGeneratedBy ECO_0000203 NP80132.RAfCDnbk6DkxE18OakphP-HxvvqWNNukxBMiHwge1SsOw130_provenance.